[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350930-105":59,"doc-detail-350930-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-novel-krt17-hnrnp-k-cxcr3-axis-promotes-esophageal-squamous-cell-carcinoma-metastasis-via-nuclear-cytoplasmic-redistribution","A novel KRT17-hnRNP K-CXCR3 axis promotes esophageal squamous cell carcinoma metastasis via nuclear-cytoplasmic redistribution","","Esophageal squamous cell carcinoma (ESCC) remains highly lethal, with patient outcome driven largely by metastatic spread. Keratin 17 (KRT17) is shown to translocate into the nucleus through its nuclear localization sequence (NLS), triggering nuclear-to-cytoplasmic redistribution of heterogeneous nuclear ribonucleoprotein K (hnRNP K). This promotes expression of CXCR3 ligands CXCL9, CXCL10 and CXCL11, activating CXCR3 signaling to enhance ESCC migration and invasion in contrast to an NLS mutant.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-krt17-hnrnp-k-cxcr3-axis-promotes-esophageal-squamous-cell-carcinoma-metastasis-via-nuclear-cytoplasmic-redistribution/350930/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-krt17-hnrnp-k-cxcr3-axis-promotes-esophageal-squamous-cell-carcinoma-metastasis-via-nuclear-cytoplasmic-redistribution/350930.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does KRT17 promote ESCC metastasis according to the study?","Question",{"text":112,"@type":113},"KRT17 enters the nucleus via its NLS, drives hnRNP K redistribution to the cytoplasm, increases CXCR3 ligand expression (CXCL9/10/11), and activates CXCR3 signaling to enhance ESCC cell migration and invasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the role of the NLS mutant KRT17-K399A?",{"text":117,"@type":113},"KRT17-K399A cannot enter the nucleus, so it fails to cause hnRNP K cytoplasmic accumulation or activate CXCR3 signaling, indicating nuclear localization is required.",{"name":119,"@type":110,"acceptedAnswer":120},"How can the pro-metastatic effects be reversed?",{"text":121,"@type":113},"Silencing hnRNP K or inhibiting the CXCR3 pathway reverses the pro-metastatic effects of KRT17; exogenous CXCL11 partially rescues cell migration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350930,1790198831,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nA novel KRT17-hnRNP K-CXCR3 axis promotes esophageal squamous cell carcinoma metastasis via nuclear-cytoplasmic redistribution  \nShaobin Yu1,7, Lin Ye1,7, Jin Huang1,7, Hui Xu1, Weiqing Wu2, Meicheng Jiang3􀀍 & Mingqiang Kang1,4,5,6􀀍  \nEsophageal squamous cell carcinoma (ESCC) is a highly lethal malignancy, in which patient prognosis is critically influenced by metastasis. While Keratin 17 (KRT17) has been implicated in tumor progression across various cancers, prior studies have primarily focused on its cytoplasmic roles. The mechanisms underlying nuclear KRT17-driven metastasis in ESCC remain unclear. Here, we demonstrate that KRT17 translocates to the nucleus via its nuclear localization sequence (NLS), thereby promoting the redistribution of heterogeneous nuclear ribonucleoprotein K (hnRNP K) from the nucleus to the cytoplasm. This shift upregulates the CXCR3 ligands CXCL9, CXCL10, and CXCL11, leading to subsequent activation of the CXCR3 signaling pathway and a marked enhancement of ESCC cell migration and invasion. In contrast, an NLS mutant (KRT17-K399A) that fails to enter the nucleus does not induce hnRNP K cytoplasmic accumulation or activate CXCR3 signaling. Furthermore, silencing hnRNP K or inhibiting the CXCR3 pathway reverses the pro-metastatic effects of KRT17, whereas exogenous CXCL11 partially rescues cell migration. Collectively, our findings unveil a novel mechanism by which overexpressed KRT17 facilitates ESCC metastasis through a nuclear localization-dependent KRT17-hnRNP K-CXCR3 axis, providing a theoretical foundation for targeting this pathway as a promising therapeutic strategy.  \nKeywords KRT17 (Keratin 17), hnRNP k (Heterogeneous nuclear ribonucleoprotein K), CXCR3 signaling pathway, Nuclear localization sequence (NLS), Esophageal squamous cell carcinoma (ESCC)  \nEsophageal cancer ranks as the sixth leading cause of cancer-related death worldwide and is among the most prevalent malignancies in China1. Studies have shown that early-stage esophageal cancer invading the lamina propria (pT1a) exhibits a lymph node metastasis rate of approximately 5%, which escalates to 17–26% when the tumor invades the submucosa (pT1b)2. Even following curative esophagectomy, distant metastasis occurs in up to 30.7% of cases3, resulting in an overall 5-year survival rate of around 20% . Lymphatic and distant metastases are major determinants of poor prognosis in esophageal squamous cell carcinoma (ESCC), underscoring the need for novel strategies to inhibit these metastatic processes and improve patient outcomes.  \nKeratin 17 (KRT17), a type I intermediate filament protein with a molecular weight of approximately 48 kDa, is expressed in several normal epithelial cell types, including myoepithelial, respiratory, urothelial, and esophageal epithelial cells4. Recent studies have revealed that KRT17 plays a critical role in modulating tumor cell growth, proliferation, and invasion5,6. In our previous work, we performed comprehensive transcriptome sequencing  \n1Department of Thoracic Surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, China. 2Department of Pathology, Fuqing City Hospital Affiliated to Fujian Medical University, Fuzhou, China.  \n3Department of Pathology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, China. 4Key Laboratory of Cardio-Thoracic Surgery, Fujian Medical University, Fuzhou, China. 5Key Laboratory of Gastrointestinal Cancer, Ministry of Education, School of Basic Medical Science, Fujian Medical University, Fuzhou, China.  \n6Department of Medical Microbiology, Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, China. 7Shaobin Yu, Lin Ye and Huang Jin contributed equally to this work. 􀀍 email: [329515022@qq.com](329515022@qq.com); [mingqiang_kang@126.com](mingqiang_kang@126.com)  \n[www. nature.com/scientificreports/](www. nature.com/scient","cbCaie4LpWtsqcKd","https://ap.wps.com/l/cbCaie4LpWtsqcKd","pdf",2001347,11,"English","# Overview\n## Clinical significance of ESCC metastasis\n## Rationale for the KRT17-hnRNP K-CXCR3 axis\n# Results\n## KRT17 overexpression and metastatic behavior","[{\"question\":\"How does KRT17 promote ESCC metastasis according to the study?\",\"answer\":\"KRT17 enters the nucleus via its NLS, drives hnRNP K redistribution to the cytoplasm, increases CXCR3 ligand expression (CXCL9/10/11), and activates CXCR3 signaling to enhance ESCC cell migration and invasion.\"},{\"question\":\"What is the role of the NLS mutant KRT17-K399A?\",\"answer\":\"KRT17-K399A cannot enter the nucleus, so it fails to cause hnRNP K cytoplasmic accumulation or activate CXCR3 signaling, indicating nuclear localization is required.\"},{\"question\":\"How can the pro-metastatic effects be reversed?\",\"answer\":\"Silencing hnRNP K or inhibiting the CXCR3 pathway reverses the pro-metastatic effects of KRT17; exogenous CXCL11 partially rescues cell migration.\"}]","A novel KRT17-hnRNP K-CXCR3 axis promotes esophageal squamous cell carcinoma metastasis via nuclear-cytoplasmic redistribution | PDF",1790091829,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39d961bfddddc7012c5c7bb5796026fa.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b193b8cda6bb219ab4dd909c45c8d8c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de92edc896684e12be8aaa415e7b6b09.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e7fc31490d04c0511708fc4a17d7394.webp",980,1287]